Evaluating transfers of patients with brain hemorrhages for advanced care
Appropriateness of MHS Inter-facility Transfers of Traumatic Intracranial Subarachnoid Hemorrhage and Spontaneous Bleeds for Level-1 Advanced Surgical Intervention
This study looks at whether patients with brain bleeding who are moved from one hospital to another are being transferred to the right place for better care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Methodist Health System Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT06136078 on ClinicalTrials.gov |
What this trial studies
This observational study assesses the appropriateness of inter-facility transfers of patients with traumatic intracranial subarachnoid hemorrhage and spontaneous bleeds to a comprehensive stroke center. It focuses on patients aged 18 and older who are transferred from Methodist Mansfield or Methodist Charlton medical centers to Methodist Dallas medical center. The study aims to analyze the rate of appropriate versus inappropriate transfers, which is crucial for ensuring that patients receive timely and effective neurological care.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with traumatic intracranial subarachnoid hemorrhage or spontaneous bleeds who are transferred from specific Methodist Health System facilities.
Not a fit: Patients who do not meet the inclusion criteria, such as those under 18 or with different types of brain injuries, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the transfer protocols for patients with brain injuries, leading to better outcomes and more efficient use of medical resources.
How similar studies have performed: While this study focuses on a specific health system's transfer protocols, similar studies evaluating transfer appropriateness in stroke care have shown promising results in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients ≥18 years old * Diagnosed with traumatic intracranial subarachnoid hemorrhage or a spontaneous bleed * Patients originating at Methodist Mansfield medical center (MMMC) or Methodist Charlton medical center(MCMC)and subsequently transferred to Methodist Dallas medical center (MDMC) Exclusion Criteria: * Does not meet inclusion criteria defined in section 3.1
Where this trial is running
Dallas, Texas
- Clinical Research Institute at Methodist Health System — Dallas, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Richard Meyrat, MD — The Methodist Hospital Research Institute
- Study coordinator: Colette Ngo Ndjom, MS
- Email: MHSIRB@mhd.com
- Phone: 214) 947-1289
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.